Klinika Burzyńskiego (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Klinika Burzyńskiego" in Polish language version.

refsWebsite
Global rank Polish rank
4th place
7th place
2nd place
6th place
1,684th place
2,913th place
1st place
1st place
5,063rd place
low place
5,225th place
3,508th place
87th place
5th place
197th place
194th place
41st place
218th place
405th place
1,589th place
447th place
1,118th place
8,518th place
low place
2,760th place
low place
1,903rd place
5,519th place
low place
low place
756th place
32nd place
634th place
1,001st place
54th place
141st place
3,680th place
6,345th place
8,489th place
low place
low place
7,248th place
1,858th place
low place
low place
9,684th place
504th place
840th place
5th place
2nd place
low place
low place
4,146th place
low place
low place
low place
low place
low place
low place
low place
3,042nd place
3,480th place
low place
low place
low place
low place
low place
low place
low place
low place
3,475th place
low place
1,047th place
925th place
1,226th place
1,204th place
7th place
29th place
856th place
4,901st place
13th place
81st place
8,028th place
low place
low place
low place
770th place
2,635th place
198th place
499th place
8th place
22nd place
8,268th place
low place
low place
low place
4,546th place
low place

archive.is

archive.ph

bbc.co.uk

bmj.com

boingboing.net

cancer.gov

cancer.org

cancerresearchuk.org

cancerhelp.cancerresearchuk.org

clinicaltrials.gov

courthousenews.com

denverpost.com

discovermagazine.com

blogs.discovermagazine.com

docs.google.com

doi.org

dx.doi.org

  • Keith I. Block, Antineoplastons and the Challenges of Research in Integrative Care, „Integrative Cancer Therapies”, 3 (1), 2004, s. 3–4, DOI10.1177/1534735404263274, PMID15035867.
  • Lessons from antineoplaston, „The Lancet”, 349 (9054), 1997, s. 741, DOI10.1016/S0140-6736(97)21011-1, PMID9091754.
  • Antineoplastons, „CA”, 33 (1), 1983, s. 57–9, DOI10.3322/canjclin.33.1.57, PMID6401577.
  • A. Vickers, Alternative Cancer Cures: ‘Unproven’ or ‘Disproven’?, „CA”, 54 (2), 2004, s. 110–8, DOI10.3322/canjclin.54.2.110, PMID15061600.
  • Eliot Marshall, The politics of alternative medicine, „Science”, 265 (5181), 1994, s. 2000-2002, DOI10.1126/science.8091220.
  • J C Buckner i inni, Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma, „Mayo Clinic Proceedings”, 74 (2) pmid=10069350, 1999, s. 137–45, DOI10.4065/74.2.137.
  • Stanislaw R. Burzynski i inni, The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma, „Child's Nervous System”, 30 (12), 2014, s. 2051–2061, DOI10.1007/s00381-014-2401-z, PMID24718705, PMCIDPMC4223571 (ang.).
  • Tai-Tong Wong, Comment to the paper "The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brain stem glioma" by Burzynski et al, „Child's Nervous System”, 30 (12), 2014, s. 2069–2070, DOI10.1007/s00381-014-2515-3, PMID25142686 [dostęp 2023-01-18] (ang.).
  • Robert Blaskiewicz, Comment to the paper: The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma : Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek, „Child's Nervous System”, 30 (12), 2014, s. 2067–2068, DOI10.1007/s00381-014-2514-4, PMID25146834 [dostęp 2023-01-18] (ang.).
  • Giorgio Perilongo, Commentary on: "The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma." By Burzynski et al, „Child's Nervous System”, 30 (12), 2014, s. 2071–2072, DOI10.1007/s00381-014-2557-6, PMID25330863 [dostęp 2023-01-18] (ang.).
  • Maura Massimino, Carlo Alfredo Clerici, Commentary: The response and survival of children with recurrent diffuse intrisic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma, by Burzynski G, et al, „Child's Nervous System”, 30 (12), 2014, s. 2065–2066, DOI10.1007/s00381-014-2511-7, PMID25079885 [dostęp 2023-01-18] (ang.).

fda.gov

forbes.com

freethoughtblogs.com

getreading.co.uk

google.co.uk

books.google.co.uk

guardian.co.uk

highbeam.com

houstonpress.com

blogs.houstonpress.com

jst.go.jp

jstage.jst.go.jp

ministryoftruth.me.uk

mskcc.org

nih.gov

ncbi.nlm.nih.gov

  • Keith I. Block, Antineoplastons and the Challenges of Research in Integrative Care, „Integrative Cancer Therapies”, 3 (1), 2004, s. 3–4, DOI10.1177/1534735404263274, PMID15035867.
  • Shannon Brownlee, Gary Cohen, Trials of a Cancer Doc: Experimental drugs and a 20-year fight with the FDA, „US News & World Report”, 125 (13), 1998, s. 28–30, 32, 35, PMID10186429 [zarchiwizowane z adresu 2012-09-15].
  • Lessons from antineoplaston, „The Lancet”, 349 (9054), 1997, s. 741, DOI10.1016/S0140-6736(97)21011-1, PMID9091754.
  • Antineoplastons, „CA”, 33 (1), 1983, s. 57–9, DOI10.3322/canjclin.33.1.57, PMID6401577.
  • A. Vickers, Alternative Cancer Cures: ‘Unproven’ or ‘Disproven’?, „CA”, 54 (2), 2004, s. 110–8, DOI10.3322/canjclin.54.2.110, PMID15061600.
  • SR Burzynski, Antineoplastons: history of the research (I), „Drugs under experimental and clinical research”, 12 (Suppl 1), 1986, s. 1–9, PMID3527634.
  • Stanislaw R. Burzynski i inni, The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma, „Child's Nervous System”, 30 (12), 2014, s. 2051–2061, DOI10.1007/s00381-014-2401-z, PMID24718705, PMCIDPMC4223571 (ang.).
  • Tai-Tong Wong, Comment to the paper "The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brain stem glioma" by Burzynski et al, „Child's Nervous System”, 30 (12), 2014, s. 2069–2070, DOI10.1007/s00381-014-2515-3, PMID25142686 [dostęp 2023-01-18] (ang.).
  • Robert Blaskiewicz, Comment to the paper: The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma : Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek, „Child's Nervous System”, 30 (12), 2014, s. 2067–2068, DOI10.1007/s00381-014-2514-4, PMID25146834 [dostęp 2023-01-18] (ang.).
  • Giorgio Perilongo, Commentary on: "The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma." By Burzynski et al, „Child's Nervous System”, 30 (12), 2014, s. 2071–2072, DOI10.1007/s00381-014-2557-6, PMID25330863 [dostęp 2023-01-18] (ang.).
  • Maura Massimino, Carlo Alfredo Clerici, Commentary: The response and survival of children with recurrent diffuse intrisic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma, by Burzynski G, et al, „Child's Nervous System”, 30 (12), 2014, s. 2065–2066, DOI10.1007/s00381-014-2511-7, PMID25079885 [dostęp 2023-01-18] (ang.).
  • M. McCartney, Texan clinic threatens UK bloggers with legal action over criticisms of its treatments, „British Medical Journal”, 343, 2011, s. d7865, PMID22138837.

nytimes.com

movies.nytimes.com

ofcom.org.uk

stakeholders.ofcom.org.uk

openjurist.org

pbs.org

quackometer.net

quackwatch.org

rhysmorgan.co

richarddawkins.net

sciencebasedmedicine.org

scienceblogs.com

scienceinmedicine.org

skepticalhumanities.com

skepticnorth.com

state.tx.us

3rdcoa.courts.state.tx.us

theness.com

usatoday.com

usnews.com

variety.com

villagevoice.com

watfordobserver.co.uk

wayne.edu

med.wayne.edu

web.archive.org

worldcat.org